Swiss Re Valuation
Is SREN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SREN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SREN (CHF110.9) is trading below our estimate of fair value (CHF370.85)
Significantly Below Fair Value: SREN is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SREN?
Other financial metrics that can be useful for relative valuation.
What is SREN's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$37.82b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.9x |
Enterprise Value/EBITDA | 7.3x |
PEG Ratio | 1.9x |
Price to Earnings Ratio vs Peers
How does SREN's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 22.4x | ||
ZURN Zurich Insurance Group | 16.7x | 7.3% | CHF 69.6b |
SLHN Swiss Life Holding | 17.3x | -0.3% | CHF 18.7b |
HELN Helvetia Holding | 25.2x | 20.5% | CHF 7.0b |
BALN Bâloise Holding | 30.2x | 19.9% | CHF 7.2b |
SREN Swiss Re | 10.3x | 5.5% | CHF 32.2b |
Price-To-Earnings vs Peers: SREN is good value based on its Price-To-Earnings Ratio (10.3x) compared to the peer average (22.4x).
Price to Earnings Ratio vs Industry
How does SREN's PE Ratio compare vs other companies in the European Insurance Industry?
Price-To-Earnings vs Industry: SREN is good value based on its Price-To-Earnings Ratio (10.3x) compared to the European Insurance industry average (10.6x).
Price to Earnings Ratio vs Fair Ratio
What is SREN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 10.3x |
Fair PE Ratio | 15.4x |
Price-To-Earnings vs Fair Ratio: SREN is good value based on its Price-To-Earnings Ratio (10.3x) compared to the estimated Fair Price-To-Earnings Ratio (15.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 110.90 | CHF 111.35 +0.4% | 13.3% | CHF 129.91 | CHF 81.79 | n/a | 15 |
Aug ’25 | CHF 108.45 | CHF 115.40 +6.4% | 13.0% | CHF 135.37 | CHF 85.23 | n/a | 15 |
Jul ’25 | CHF 112.40 | CHF 114.76 +2.1% | 12.9% | CHF 135.03 | CHF 83.20 | n/a | 15 |
Jun ’25 | CHF 114.70 | CHF 114.29 -0.4% | 13.0% | CHF 135.08 | CHF 84.97 | n/a | 15 |
May ’25 | CHF 99.82 | CHF 111.91 +12.1% | 13.0% | CHF 135.71 | CHF 85.41 | n/a | 15 |
Apr ’25 | CHF 115.95 | CHF 111.06 -4.2% | 12.8% | CHF 133.16 | CHF 88.34 | n/a | 15 |
Mar ’25 | CHF 106.30 | CHF 107.85 +1.5% | 12.4% | CHF 130.56 | CHF 86.62 | n/a | 16 |
Feb ’25 | CHF 97.76 | CHF 104.61 +7.0% | 11.4% | CHF 124.91 | CHF 84.51 | n/a | 16 |
Jan ’25 | CHF 94.56 | CHF 100.26 +6.0% | 11.3% | CHF 121.77 | CHF 80.54 | n/a | 16 |
Dec ’24 | CHF 98.34 | CHF 102.05 +3.8% | 12.3% | CHF 125.86 | CHF 82.24 | n/a | 16 |
Nov ’24 | CHF 100.95 | CHF 99.67 -1.3% | 14.3% | CHF 129.31 | CHF 77.58 | n/a | 16 |
Oct ’24 | CHF 94.32 | CHF 99.63 +5.6% | 13.8% | CHF 131.28 | CHF 78.76 | n/a | 16 |
Sep ’24 | CHF 85.64 | CHF 97.20 +13.5% | 15.9% | CHF 141.11 | CHF 75.60 | n/a | 16 |
Aug ’24 | CHF 90.90 | CHF 95.45 +5.0% | 12.6% | CHF 117.01 | CHF 73.53 | CHF 108.45 | 16 |
Jul ’24 | CHF 90.04 | CHF 97.20 +7.9% | 12.7% | CHF 120.46 | CHF 75.70 | CHF 112.40 | 17 |
Jun ’24 | CHF 92.78 | CHF 97.12 +4.7% | 13.0% | CHF 121.81 | CHF 76.54 | CHF 114.70 | 18 |
May ’24 | CHF 89.72 | CHF 94.27 +5.1% | 13.2% | CHF 116.06 | CHF 72.45 | CHF 99.82 | 18 |
Apr ’24 | CHF 93.84 | CHF 94.61 +0.8% | 13.5% | CHF 118.61 | CHF 74.03 | CHF 115.95 | 18 |
Mar ’24 | CHF 97.50 | CHF 96.96 -0.6% | 13.5% | CHF 121.97 | CHF 76.14 | CHF 106.30 | 18 |
Feb ’24 | CHF 94.38 | CHF 89.55 -5.1% | 11.9% | CHF 111.93 | CHF 70.65 | CHF 97.76 | 18 |
Jan ’24 | CHF 86.48 | CHF 81.34 -5.9% | 12.3% | CHF 107.08 | CHF 62.94 | CHF 94.56 | 18 |
Dec ’23 | CHF 84.98 | CHF 80.28 -5.5% | 11.7% | CHF 108.23 | CHF 63.62 | CHF 98.34 | 18 |
Nov ’23 | CHF 74.72 | CHF 83.02 +11.1% | 14.0% | CHF 115.52 | CHF 54.30 | CHF 100.95 | 19 |
Oct ’23 | CHF 73.16 | CHF 88.19 +20.5% | 10.1% | CHF 115.62 | CHF 72.56 | CHF 94.32 | 19 |
Sep ’23 | CHF 76.18 | CHF 86.47 +13.5% | 12.0% | CHF 117.55 | CHF 68.42 | CHF 85.64 | 19 |
Aug ’23 | CHF 71.30 | CHF 85.36 +19.7% | 11.9% | CHF 115.36 | CHF 68.03 | CHF 90.90 | 18 |
Analyst Forecast: Target price is less than 20% higher than the current share price.